Sexual Health

It is the clinic's collection of educational information and prescription treatment options related to erectile function, ejaculation concerns, women's intimate wellness, and herpes management. The available choices depend on a clinician's assessment and the current catalog.

Erectile dysfunction is one part of sexual wellness. The expanded collection also discusses premature ejaculation, women's arousal options, oxytocin formulations, and antiviral treatment for HSV.

Yes. Review product cards, ingredients, formulation comparisons, and FAQs to understand the options. Reading a product page does not mean a medication is appropriate for you.

Start with the concern most relevant to you, such as difficulty maintaining an erection, ejaculation timing, changes in arousal, or recurrent herpes outbreaks. The page's guided finder can organize your questions but cannot replace a clinical assessment.

The comparison feature should display verified ingredients, dosage form, strengths, and other product facts when available. Different medications should not be ranked as universally better or safer for everyone.

Not necessarily. Product mockups are illustrative; the dispensing pharmacy's actual packaging, labeling, and appearance may differ. The prescription label identifies the medication supplied.

Names such as SPARK or ENDURE help organize the storefront. The actual active ingredient, strength, and dosage form are more important for understanding what the medication contains.

No. Some standard manufactured medications have FDA-approved versions, while customized combination products, creams, troches, or dissolving formulations may be compounded. Compounded medications are not FDA-approved.

Use the current product card and confirmed checkout or consultation pathway. Availability and formulations can change, and the clinic should verify any item whose listing is pending or unclear.

Sometimes. Blood vessel health affects erections, and new ED can warrant evaluation for blood pressure, diabetes, cholesterol, and cardiovascular risk rather than only symptom treatment.

No. ED can occur at many adult ages, and a person's health history, medications, and circumstances matter more than age alone.

No. Low testosterone can contribute in some patients, but ED often has vascular, neurologic, medication-related, or psychological causes. Testosterone is not a substitute for a full evaluation.

Yes. Morning erections may offer clues but do not rule out ED. A clinician considers the full pattern, medical history, and associated symptoms.

Not necessarily. Erectile function and sperm production are different processes, although ED can interfere with attempts to conceive.

Exercise, improved sleep, smoking cessation, reduced excess alcohol, and management of diabetes or hypertension may improve overall health and erectile function. Results vary by cause.

Seek evaluation for new, persistent, painful, or rapidly worsening symptoms; chest symptoms; pelvic injury; significant urinary symptoms; or concerns about medication interactions. Sudden severe symptoms require urgent care.

Erectile dysfunction (ED) is difficulty getting or maintaining an erection firm enough for satisfactory sexual activity. It can happen occasionally or become an ongoing concern.

ED can have several contributing factors, including circulation, diabetes, cardiovascular health, medications, hormone changes, stress, and other medical conditions. A provider can help evaluate which factors may be relevant to you.

ED becomes more common with age, but it is not something you automatically have to accept. Treatment options may help, depending on your health and the underlying causes.

Yes. Stress, anxiety, relationship concerns, and performance pressure can affect erections. Physical and psychological factors can also occur together.

Sometimes. ED may be associated with cardiovascular disease, diabetes, hormonal concerns, or other health issues. A medical evaluation considers your overall health as well as your symptoms.

Medications such as sildenafil, tadalafil, and vardenafil support the physical erection response during sexual stimulation. They do not directly increase sexual desire or testosterone levels.

A phosphodiesterase type 5 inhibitor is a medication that helps support blood flow involved in erections during sexual stimulation. Sildenafil, tadalafil, and vardenafil belong to this family.

No. PDE5 inhibitors support the body's erectile response to sexual stimulation; they do not usually produce an erection in the absence of arousal.

Do not combine PDE5 inhibitors on your own. A specifically prescribed compounded combination is different from self-combining separate medications and still requires individual assessment.

No. Milligram amounts are not directly comparable across different active drugs or combination products. A higher labeled strength can also increase adverse effects.

No. A troche is a preparation intended to dissolve in the mouth, while standard tablets are swallowed. Absorption, instructions, and evidence may differ by formulation.

The decision should reflect the actual problem being treated, prior response, medical history, drug interactions, and the limited evidence for some compounded combinations. More ingredients do not automatically mean better outcomes.

Sildenafil is a prescription PDE5 inhibitor commonly used to treat erectile dysfunction. It supports blood flow during sexual stimulation and is generally used as needed; it does not cause an erection without stimulation.

Tadalafil is a prescription ED medication known for its longer duration of action. Depending on the prescribed regimen, it may be used as needed or once daily.

Vardenafil is another prescription medication used to treat ED. Like sildenafil and tadalafil, it supports blood flow during sexual stimulation, but its dosing and interaction considerations differ.

Both are PDE5 inhibitors that support erections during sexual stimulation. Tadalafil can provide a window of action up to 36 hours, while sildenafil is shorter-acting; tadalafil has as-needed and once-daily prescription options.

Both are PDE5 inhibitors generally used as needed, but interactions and individual response differ. Vardenafil should be avoided by people with congenital QT prolongation or those taking certain class IA or III antiarrhythmic medicines; your provider reviews these heart-rhythm risks.

Cialis is the brand-name version of tadalafil. FDA-approved generic tadalafil contains the same active ingredient and must meet applicable generic approval standards, although inactive ingredients, appearance, and price may differ.

Onset varies by medication, formulation, meals, and individual response. No single medication is guaranteed to work fastest for every patient, and compounded dosage forms should not be assumed to act faster without supporting evidence.

Tadalafil generally provides a longer window of action than sildenafil or vardenafil. That does not mean a continuous erection; sexual stimulation is still needed.

Your provider may consider a different medication if your current treatment is not giving you the desired results. Do not combine or switch medications without appropriate prescribing instructions.

An oral tablet is swallowed according to its prescribing instructions. Commercially manufactured ED tablets are available in different strengths depending on the medication.

An orally disintegrating tablet is designed to break apart in the mouth. Administration instructions vary by product, and an ODT should not automatically be considered equivalent to every conventional tablet or compounded formulation.

A troche is a medication preparation designed to dissolve gradually in the mouth. It is typically compounded, and the specific prescription instructions determine where to place it and how to use it.

A conventional tablet is generally swallowed, while a troche dissolves in the mouth. The formulation may affect how medication is administered and absorbed, but neither format is automatically more effective.

An ODT is formulated to disintegrate in the mouth, while a troche typically dissolves more gradually. Their ingredients, absorption, and dosing instructions may differ, so they should not be treated as interchangeable.

A compounded capsule is prepared using a patient-specific formulation when a provider determines that a commercially available drug does not appropriately meet the patient’s medical needs. It is not an FDA-approved finished drug product.

No. Available tablets, ODTs, troches, capsules, and injectable products depend on the specific medication and the verified pharmacy catalog. Your available options are displayed when you configure a treatment.

You can explore available medication strengths, but a licensed prescribing provider determines whether treatment is appropriate and which medication, formulation and dose are suitable. Selecting an option here is not self-prescribing.

SPARK is the storefront name for a sildenafil orally dissolving formulation. The ingredient is sildenafil; the dosage form and exact prescribed strength must be verified on the product listing and label.

A high-fat meal can delay the onset of the approved swallowed tablet. The effect of food and mouth-dissolving administration should be confirmed for the actual dispensed formulation.

Headache, flushing, stuffy nose, indigestion, and dizziness are recognized effects. Visual changes can occur; sudden vision loss needs urgent assessment.

Both may contain sildenafil, but a compounded orally dissolving product is not automatically equivalent to an FDA-approved Viagra tablet. Ingredients, formulation, and instructions should be checked.

Frequency depends on the prescribed formulation and the clinician's instructions. Do not increase frequency or take additional ED agents without approval.

No. Sildenafil and nitrates can cause dangerous low blood pressure. Tell your clinician about nitroglycerin, other nitrate prescriptions, and recreational poppers.

Do not take extra doses to compensate. Timing, stimulation, food, underlying health factors, and correct use may matter; discuss the experience with the prescriber before changing anything.

ENDURE is the storefront name for tadalafil oral tablets. Confirm the exact product strength and whether the listing refers to an FDA-approved manufactured tablet or another formulation.

Cialis is a brand-name FDA-approved tadalafil tablet used for ED and certain urinary symptoms related to benign prostatic hyperplasia. Brand and generic sourcing, pricing, and availability should be checked on the active storefront.

FDA-approved Cialis tablets may improve erectile function for up to 36 hours after dosing. That does not mean an erection lasts for 36 hours.

No. FDA-approved tadalafil has both as-needed and once-daily treatment regimens depending on indication and clinician selection. Do not switch schedules without guidance.

No. It takes time for the medication to absorb and work, and sexual stimulation is still generally needed. Timing varies among patients.

The FDA-approved oral tablet may be taken with or without food. Other compounded tadalafil dosage forms can have different instructions.

Headache, indigestion, flushing, nasal congestion, back pain, and muscle aches can occur. Serious symptoms such as chest pain or a prolonged erection require urgent evaluation.

FDA-approved tadalafil tablets have approved indications for ED and symptoms of benign prostatic hyperplasia. Whether a particular patient should use it for either indication requires evaluation.

Its blood-pressure interaction with nitrates is dangerous, and the longer duration can complicate emergency nitrate treatment. Anyone with chest pain after tadalafil should seek urgent help and tell clinicians when the last dose was taken.

It is the storefront name for a tadalafil orally dissolving formulation. Its precise ingredients, strength, and instructions are determined by the approved product data and dispensing label.

ENDURE TROCHE is a tadalafil formulation designed to dissolve in the mouth. It is not the same dosage form as an FDA-approved swallowed Cialis tablet.

No. Compounded drugs are not FDA-approved and have not undergone FDA premarket review for safety, effectiveness, or quality.

No. Faster action should not be promised without product-specific supporting evidence. Absorption and clinical response depend on the formulation and the patient.

Use the exact instructions printed by the dispensing pharmacy. Do not assume a troche should be chewed, swallowed whole, or held in a particular part of the mouth.

Do not independently substitute dosage forms or strengths. The pharmacist and prescriber should confirm whether a change is appropriate.

Some preparations contain flavorings, sweeteners, dyes, or other inactive ingredients. Ask the pharmacy for a complete ingredient list if you have allergies or sensitivities.

Not without explicit prescribing instructions. Both contain tadalafil, and doubling up can increase adverse effects.

Dosage forms may address swallowing preferences or individualized prescribing needs. Their existence does not establish that one form is clinically superior to another.

PULSE is the brand family for vardenafil treatments. The exact listing must identify whether it is a swallowed tablet, dissolving tablet, or troche.

Vardenafil is a PDE5 inhibitor used for erectile dysfunction. It supports erection-related blood flow during sexual stimulation.

No. They are different active ingredients in the same medication class and have different prescribing and interaction considerations.

It is the vardenafil orally dissolving option. Verify whether the item is a compounded preparation or an approved manufactured formulation before describing its regulatory status.

PULSE TROCHE refers to a vardenafil preparation made to dissolve in the mouth. Follow the dispensed product's specific instructions.

No. Vardenafil should not be combined with nitrates because of potentially dangerous drops in blood pressure.

Do not combine it with sildenafil, tadalafil, or other PDE5 inhibitors unless a clinician has explicitly prescribed and evaluated a specific regimen.

Not automatically. Dosing and exposure may differ by dosage form, and the actual pharmacy product should be checked.

Headache, flushing, nasal congestion, dizziness, or indigestion may occur. New chest symptoms, sudden vision or hearing changes, or an erection lasting over four hours require urgent care.

SURGE is the name for a sildenafil-plus-tadalafil orally dissolving formulation. It combines two PDE5 inhibitors and requires a careful individualized review.

A prescriber may consider a compounded combination for a specific clinical reason, but combining medications is not automatically more effective and can increase side effects. Product-specific clinical evidence may be limited.

The active ingredients overlap, but a compounded combination has its own ingredients, dose, instructions, and risks. Do not assume it is equivalent to taking approved tablets together.

Yes. Both ingredients affect blood-vessel signaling, and combining them may increase blood-pressure-related symptoms, especially with alcohol or interacting medicines.

No additional PDE5 inhibitor should be taken unless the prescriber explicitly directs it. Tell the clinician about any medications already taken that day or in previous days.

A compounded sildenafil-plus-tadalafil combination is not FDA-approved, even though each ingredient appears separately in FDA-approved drugs.

A longer or stronger effect cannot be assumed from the combination. Response and risk depend on dose, formulation, timing, and the individual patient.

Disclose heart disease, blood-pressure issues, nitrate use, alpha blockers, previous reactions to PDE5 inhibitors, and all other medications and supplements.

Avoid taking more medication, and contact the prescribing team. Fainting, chest pain, or other severe symptoms warrant urgent medical attention.

No. First-line options and the need for a compounded combination should be determined individually. More complex therapy is not always a better starting point.

A compounded medication is prepared with ingredients or a dosage form for a patient’s specific medical need when an FDA-approved drug is not appropriate. Compounded medications are not FDA-approved.

FDA-approved commercial medications have undergone the applicable regulatory review for safety, effectiveness, and quality. Compounded medications are individualized preparations and have not undergone FDA approval as finished products.

A provider may consider a compounded formulation when an available FDA-approved product does not appropriately meet an individual patient’s medical needs. The choice depends on the patient’s medical history, treatment goals, and clinical assessment.

Some compounded formulations contain more than one active ingredient. Each ingredient introduces its own prescribing considerations, so these products require evaluation of the complete combination rather than just one component.

No. These ingredients have different pharmacologic effects and may introduce additional medication interactions or precautions. Whether a particular combination is appropriate requires an individualized provider assessment.

Using two medications from the same ED drug class may increase adverse-effect and interaction concerns. Patients should not combine them unless specifically directed by an appropriately qualified prescribing provider.

Injectable ED therapies are represented here as options to discuss with a provider, not as medications available to purchase online. They require additional clinical assessment and may require hands-on training or an in-person visit.

Injectable treatments deliver medication directly into erectile tissue rather than being swallowed or dissolved in the mouth. They have different administration instructions, potential complications, and training requirements.

It is the sildenafil-plus-oxytocin orally dissolving combination. Verify the exact ingredient amounts and dosage form in the active product listing.

It is the tadalafil-plus-oxytocin orally dissolving combination. Its risks and instructions differ from those of tadalafil-only medication.

Oxytocin is being explored for potential roles in social and sexual responses, while the PDE5 ingredient supports erection-related blood flow. Evidence does not establish that the combination reliably improves intimacy or sexual satisfaction.

Compounded oxytocin-plus-PDE5 combinations are not FDA-approved and are not established as clinically equivalent to approved ED tablets.

No. A PDE5 inhibitor still generally depends on sexual stimulation, and oxytocin has not been established as a substitute for sexual desire or relationship factors.

No. The sildenafil or tadalafil component creates a serious nitrate interaction risk, regardless of the added oxytocin.

No. SPARK BOND contains sildenafil plus oxytocin, whereas BOND is the oxytocin-only orally dissolving product.

No. ENDURE BOND is a tadalafil-plus-oxytocin oral combination; BOND MIST is an oxytocin-only nasal preparation.

A licensed prescriber should review the intended use, evidence limitations, medication interactions, pregnancy considerations where applicable, and underlying sexual-health concerns.

PE generally refers to ejaculation occurring sooner than desired with difficulty delaying it and associated distress. The pattern, duration, and context help determine whether evaluation or treatment is appropriate.

Paroxetine is an SSRI, not an ED medication. It may delay ejaculation in some patients, while the paired PDE5 inhibitor targets erectile function; paroxetine itself can also cause sexual side effects.

In the United States, paroxetine use for PE is off-label. An off-label use can be clinically considered but should not be represented as an FDA-approved PE indication.

Nausea, sleep changes, sweating, sexual dysfunction, and mood effects are possible. It can also cause discontinuation symptoms if stopped abruptly after ongoing use.

Not without careful review. Combining serotonergic drugs can raise the risk of serotonin syndrome and other interactions; provide a full medication list.

No permanent cure should be promised. Management may involve medication, behavioral approaches, addressing anxiety, and treatment of any contributing erectile dysfunction.

DRIVE is the family of compounded troches combining a PDE5 inhibitor with apomorphine. It is distinct from the tadalafil-only ENDURE family.

The catalog specifies sildenafil plus apomorphine 100/6 mg in a troche. These are product formulation values, not personalized dosing instructions.

The catalog specifies tadalafil plus apomorphine 40/6 mg in a troche. A clinician must determine whether this compounded combination is suitable.

The catalog specifies vardenafil plus apomorphine 40/8 mg in a troche. Do not substitute tadalafil or a regular tablet image for this product.

Apomorphine is a dopamine-receptor agonist with approved uses in certain Parkinson disease treatments. Its use in compounded sexual-health troches is different and is not an FDA-approved ED indication.

The ingredients act through different pathways, but that theoretical rationale does not guarantee improved results. The evidence for an individual compounded combination should be discussed with the prescriber.

Yes. Nausea, dizziness, low blood pressure, and fainting are important concerns with apomorphine exposure. Individual risks and drug interactions need assessment.

No. Compounded troche combinations have not been FDA-approved for safety or effectiveness, even when some component medications have separate approved uses.

Do not add sildenafil, tadalafil, vardenafil, or a similar ED medication unless the prescriber has explicitly accounted for overlapping ingredients and dosing.

Follow the specific pharmacy label for how to place, dissolve, and time the troche. Do not assume the directions match those for a swallowed ED tablet or another compounded product.

RISE is the brand name for a tadalafil-plus-phentolamine oral capsule combination. Its catalog formulation is 25/3 mg per capsule, subject to pharmacy verification.

Tadalafil is a PDE5 inhibitor, while phentolamine blocks alpha-adrenergic receptors. Combining vascular effects may also increase the risk of blood-pressure changes.

No. This specific compounded combination is not an FDA-approved ED product. It should not be described as an approved Cialis equivalent.

Phentolamine is an alpha-adrenergic blocking drug with separate medical uses. An oral compounded combination for ED is a different use and formulation.

Yes. Both ingredients can affect vascular tone. Patients should discuss blood-pressure problems, fainting, dehydration, and interacting medications with their clinician.

No. The RISE formulation contains tadalafil and phentolamine; sildenafil is not one of its named active ingredients.

Do not combine them without prescriber review. Additional alpha-adrenergic effects can increase the risk of symptomatic hypotension.

ENDURE contains tadalafil alone in its regular tablet version; RISE adds phentolamine and is a compounded combination, with additional considerations.

No. A prior lack of response should prompt evaluation of the cause and medication use; adding an ingredient cannot guarantee success.

No. The tadalafil ingredient has a serious interaction with nitrates and certain other blood-pressure-affecting drugs.

AROUSE is the women's topical arousal-cream family. It includes two different compounded formulations and is not the same as an oral ED tablet.

The provided formulations differ primarily in the inclusion of L-arginine in AROUSE 01. Do not assume that difference guarantees better results for any particular person.

No. These compounded multi-ingredient creams are not FDA-approved and lack the same premarket evidence review required for approved drugs.

Application location, amount, and frequency should come directly from the prescriber and pharmacy instructions. Do not assume a general cosmetic cream's directions apply to intimate tissue.

Yes. Burning, redness, sensitivity, rash, or discomfort may occur with topical ingredients. Stop using it and contact the prescriber if irritation occurs.

A topical arousal formula is not proven to correct every cause of low desire. Desire involves hormonal, physical, psychological, relational, and medication-related factors.

No. It is a compounded medication, not a standard lubricant or vaginal moisturizer. Dryness or painful intercourse may require a different evaluation and treatment approach.

Transfer is a concern to discuss for topical prescriptions, particularly with intimate contact. Follow the product's instructions on timing, washing, and contact precautions.

DESIRE is the name for the women's intimate-wellness collection within the storefront. It is a category or navigation label, not a separate drug.

Educational topics may include changes in arousal, discomfort, reduced interest in intimacy, and medication-related sexual symptoms. Individual concerns can have different causes and treatments.

No. Desire refers to interest in sexual activity; arousal includes physical and subjective responses. They can overlap but should not be assumed to be identical.

Yes. Hormonal changes, vaginal dryness, sleep disturbances, mood changes, and other factors may influence sexual comfort and interest. Appropriate evaluation is individualized.

No. Pain can be caused by dryness, infection, pelvic-floor dysfunction, skin disorders, endometriosis, or other problems that deserve evaluation.

Yes. Some antidepressants can lower libido, delay orgasm, or change arousal. Do not stop a prescribed mental-health medication without discussing alternatives with the prescriber.

Not in the current Sexual Wellness medication inventory used for this FAQ library. Hormone-care services may be described elsewhere on the LPWWC website.

No. It is reasonable to describe what has changed and what matters to you. A clinician can explore medical, medication-related, hormonal, and relational contributors.

Yes. Sexual symptoms are not determined by one hormone level alone, and normal laboratory results do not invalidate a patient's experience.

No. Pregnancy and breastfeeding create important medication-safety questions, especially for compounded formulas and oxytocin products. Confirm suitability with the treating clinician.

BOND is the name for an oxytocin orally dissolving tablet. The supplied catalog lists 200 IU per tablet; that is a formulation specification, not an instruction to take it.

BOND MIST is the oxytocin nasal spray formulation, listed as 100 IU/mL in a 10 mL bottle. Actual administration instructions must come from the pharmacy and prescriber.

Oxytocin is a naturally occurring hormone with established roles in uterine contraction and milk ejection. Those roles do not establish effectiveness for sexual desire or relationship bonding.

No reliable improvement should be promised. Studies of intranasal oxytocin and sexual response have had mixed or negative results, including studies without a significant benefit over placebo.

No. It is a medication formulation intended for nasal administration only when appropriately prescribed. It should not be used like an over-the-counter fragrance or decongestant.

No. Oral dissolving tablets and nasal sprays differ in delivery and potentially absorption; do not swap forms or compare IU amounts as equivalent doses.

No. These compounded products are not FDA-approved for improving sexual function or bonding.

Side effects and systemic exposure depend on formulation and dose. Patients should report headache, dizziness, nasal irritation, or unusual symptoms and discuss the uncertain evidence with the prescriber.

Do not use an oxytocin sexual-wellness product during pregnancy without specialized medical review. Oxytocin has uterotonic effects, and an elective compounded product should not be treated as benign.

BOND contains only oxytocin; SPARK BOND and ENDURE BOND additionally contain sildenafil or tadalafil, introducing PDE5 inhibitor risks and contraindications.

CLEAR is the storefront name for oral valacyclovir, an antiviral used for herpes simplex virus (HSV) management. The inventory includes 500 mg and 1,000 mg tablet options.

No. Valacyclovir treats episodes and can suppress recurrences, but HSV remains in the body. It does not eradicate latent infection.

Episodic therapy is taken around an outbreak to reduce symptoms and duration. Suppressive therapy is taken on a regular schedule to reduce recurrences and, in some situations, transmission risk.

Valacyclovir has approved uses that include herpes labialis and genital herpes. The exact use and regimen depend on diagnosis and patient characteristics.

No. Daily suppression can reduce certain HSV-2 transmission risks but cannot eliminate them. Avoiding sexual contact during symptoms and using barriers still matter.

Yes. Asymptomatic viral shedding can occur. A person may transmit HSV even when no lesions are visible.

For recurrent genital herpes, treatment is most effective when begun during early symptoms or promptly at lesion onset. Follow the clinician's prescribed plan, not a generic dose found online.

No. Strength is selected for a specific indication, schedule, kidney function, and clinical history. The higher strength is not automatically the better choice.

Headache and gastrointestinal symptoms can occur. Dose adjustments may be necessary in kidney disease, and adequate hydration can be important for some patients.

A clinician may use a lesion swab or type-specific blood testing depending on symptoms and history. Testing options and interpretation should be discussed rather than relying on appearance alone.

Seek emergency medical care immediately. Priapism can damage erectile tissue if treatment is delayed.

Stop activity and seek emergency care. Tell emergency clinicians exactly which ED medication you used and when, particularly because nitrates may be unsafe.

Stop the medication and seek urgent medical evaluation. Sudden loss of vision can be a serious medical event regardless of whether the drug caused it.

Stop taking the ED medication and get urgent medical advice. Sudden hearing loss or fainting should not be ignored.

Some can, but a clinician must review cardiovascular stability, whether sexual activity is safe, and medication interactions. Recent serious cardiac events may change the plan.

They can. Effects may be more pronounced with nitrates, alpha blockers, certain blood-pressure medicines, alcohol, or compounded combinations.

Do not exceed the prescribed directions or add another ED product. Excess dosing can increase serious adverse effects.

No. Age alone does not determine suitability, but kidney function, heart conditions, other medications, and sensitivity to drug effects become especially relevant.

Contact the treating team for individualized guidance; urgent symptoms warrant urgent care. Never abruptly stop ongoing antidepressant therapy such as paroxetine without discussing a plan.

Not everyone needs the same laboratory tests. Your provider reviews your medical history and symptoms to determine whether testing is appropriate or necessary.

Low testosterone can contribute to reduced sexual desire and may coexist with ED. However, many cases of ED involve other factors, including circulation, medication effects, and medical conditions.

Depending on your history, a provider may consider testing related to testosterone, blood glucose, cholesterol, or other relevant health factors. The exact tests depend on clinical assessment.

No optional blood panels are currently available to add to this ED order online. Contact LPWWC to discuss appropriate laboratory testing; no testing charge is included in the displayed total.

Secure laboratory-result uploading is not available in this ED workflow. Contact LPWWC about how to provide existing results for review; a provider determines whether they are relevant and sufficiently recent.

No. Laboratory testing is separate from hormone treatment. A provider must evaluate the results and determine whether any additional care is appropriate.

Start by exploring a medication configuration in Build Your Prescription. This page offers medication selection and pricing review, but online medical assessment and purchasing are unavailable; contact LPWWC for clinical evaluation. Provider review occurs after the required clinical information is obtained, not merely after selecting a medication.

A clinical evaluation may require information about symptoms, medical conditions, current medications, allergies, treatment history and identity. This page does not currently collect that medical information; LPWWC can explain the appropriate clinical next step.

Some ED medications affect blood pressure or interact with other medicines. Your medical history helps the provider evaluate safety and identify when additional assessment is needed.

ED medications such as sildenafil, tadalafil, and vardenafil must not be used with nitrates because the combination can cause a dangerous drop in blood pressure. Tell your provider about all nitrate medications and recreational nitrites before treatment.

Your provider can review which treatments you’ve used, their strengths, how you took them, and whether you experienced side effects. That information helps guide the discussion about appropriate alternatives or additional evaluation.

If treatment is not appropriate, no prescription is written. A provider may request more information, recommend testing or discuss another treatment pathway; payment never guarantees prescription approval. Any financial handling must follow LPWWC’s actual approved terms.

Common side effects of certain oral ED medications include headache, flushing, nasal congestion and digestive discomfort. Chest pain or an erection lasting more than four hours requires immediate medical help; stop sexual activity for chest pain and tell emergency clinicians when you last took an ED medicine. Stop the medication and seek prompt medical attention for sudden vision loss or sudden hearing decrease or loss.

Prescription renewals depend on the medication, your response to treatment, and any follow-up or monitoring required by the provider. A subsequent refill request requiring a new provider review carries one $25.00 Provider Review & Processing fee.

ED and sexual-wellness drugs can interact with heart drugs, antidepressants, alpha blockers, antifungals, antivirals, and other prescriptions. A complete list helps the prescriber avoid unsafe combinations.

Excess alcohol can worsen erections, increase dizziness, and add to blood-pressure effects. Discuss drinking patterns and specific medication instructions with your clinician.

Yes. Using them together may cause symptomatic low blood pressure. The prescriber may need to evaluate stability, timing, and dosing.

It is a potentially serious reaction linked to excess serotonin activity, usually involving interacting medications. Symptoms can include agitation, sweating, fever, diarrhea, tremor, and muscle rigidity and require urgent care.

Some medicines alter the enzymes that process PDE5 inhibitors and can raise drug exposure. Dose adjustments or alternative treatment may be needed.

Yes. Kidney function may change the safe dose or schedule of tadalafil, sildenafil, valacyclovir, and other products. Tell the prescriber about kidney disease or dialysis.

Liver disease may affect drug metabolism and the suitability of some medications or formulations. The correct plan depends on the diagnosis and severity.

Yes. Some supplements affect blood pressure, bleeding, or drug metabolism, and some sexual-enhancement products contain undisclosed prescription ingredients. Share everything you take.

Yes. Communication, expectations, conflict, and anxiety can affect arousal and satisfaction alongside physical health. Medical treatment and relationship support can complement each other.

Sleep deprivation and sleep disorders can affect mood, energy, and sexual function. Addressing sleep issues may be an important part of care.

The relationship is complex, and one universal cause cannot be assumed. If a person notices distress or changes in arousal patterns, a clinician or qualified therapist can help explore the context without judgment.

Yes. Behavioral and psychological approaches may be useful, sometimes in combination with medication. The right approach depends on the individual's symptoms and preferences.

It depends on recovery and cardiovascular stability. Patients should ask their cardiology or treating team about timing and whether sexual activity and ED medications are safe.

Yes. Diabetes can affect nerves, blood vessels, hormones, and vaginal health, and management of blood glucose may support broader sexual wellbeing.

Yes. Partners can have different needs or health conditions, and supportive communication may help. Each person needs their own evaluation and prescription when medication is considered.

Not necessarily. Medication may target a specific physical or neurochemical process, while emotional connection, consent, comfort, and communication involve additional factors.

No. Selecting a medication here does not submit a treatment request or guarantee a prescription. A licensed provider must evaluate your medical information and determine whether treatment is appropriate.

Online ED medical assessment is not currently available through this page. Contact LPWWC to discuss the appropriate evaluation pathway and whether remote care, testing or an in-person visit is needed.

Not by itself. Educational preference tools organize interests; a formal medical history or secure clinical questionnaire may be required separately.

You may be able to identify multiple interests, but a provider must assess overlapping active ingredients, drug interactions, and whether any combination is appropriate.

Covers provider evaluation of your treatment request and associated prescription processing. Each new prescription request requiring review carries this fee. Prescription approval is determined by your provider.

The fee is shown once per applicable prescription request, separately from medication and selected laboratory services. Medication selections, questions and checkout navigation do not add another fee.

Applicable standard pharmacy shipping and dispensing costs are included in the configured medication price. They are not added a second time at checkout.

Confirm the dispensing pharmacy's current packaging process before promising discreet labeling or shipping. Prescription bottles still require legally appropriate labeling.

Policies depend on whether clinical review, compounding, dispensing, or shipping has begun. Display the current approved terms before checkout; do not invent blanket medication-return promises.

Health and payment information should only be handled through the clinic's approved secure systems and authorized care or processing partners. The current privacy notice and consent forms govern specific uses; avoid entering medical history into an ordinary marketing form.

Pricing depends on the selected medication, formulation, strength, quantity, and fulfillment configuration. The treatment builder displays the applicable member medication price for your selection.

Covers provider evaluation of your treatment request and associated prescription processing. Each new prescription request requiring review carries this fee. Prescription approval is determined by your provider.

The fee is shown once per applicable prescription request, separately from medication and selected laboratory services. Medication selections, questions and checkout navigation do not add another fee.

Applicable standard pharmacy shipping and dispensing costs are included in the configured medication price. They are not added a second time at checkout.

Prices can differ based on the active ingredients, manufacturer, formulation, strength, package quantity, and fulfillment requirements. Your order total reflects the specific configuration selected.

Those quantities are available for certain oral medication configurations. The treatment builder shows the verified quantities offered for each product; specialty products may use different units.

No. Selecting a medication here does not submit a treatment request or guarantee a prescription. A licensed provider must evaluate your medical information and determine whether treatment is appropriate.

Telehealth means an approved prescription is fulfilled through an eligible pharmacy and shipped to your home. Local Pickup means an approved medication is dispensed through the LPWWC clinic in Laramie.

Eligible medication configurations may have a Telehealth home-delivery pathway listed in the medication selector. Delivery eligibility and service location require clinic confirmation; selecting that pathway does not place an order.

Yes, for eligible medications approved for local dispensing. Pickup takes place at LPWWC in Laramie after provider approval and clinic coordination.

For applicable local dispensing, the clinic may schedule a brief visit for vitals and medication pickup after provider approval. Home-delivery prescriptions do not require a pickup visit, although a provider may still require additional clinical evaluation.

Online ED medical assessment is not currently available through this page. Contact LPWWC to discuss the appropriate evaluation pathway and whether remote care, testing or an in-person visit is needed.

You can explore either available fulfillment method during treatment selection. Whether you can change your route depends on the medication configuration and whether the prescription or fulfillment process has already begun.

The clinic coordinates the pickup appointment after the provider approves the prescription. Patients do not self-schedule dispensing visits through this page.